What is it about?
The study investigates the association between the expression of the mitochondrial enzyme aldehyde dehydrogenase 2 (ALDH2) and lung adenocarcinoma (LUAD), revealing that higher expression of ALDH2 is predictive of improved overall survival and correlates with immune cell infiltration, suggesting its potential as a predictive marker for immunotherapeutic response in LUAD. These results are particularly relevant for the high incidence in the East Asian population of the rs671 polymorphism that causes ALDH2 loss of function leading to increased alcohol sensitivity (Asian Flush Syndrome).
Featured Image
Photo by Europeana on Unsplash
Read the Original
This page is a summary of: Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy, Cancer Innovation, December 2024, Wiley,
DOI: 10.1002/cai2.149.
You can read the full text:
Resources
Contributors
The following have contributed to this page